Efficacy and safety of minocycline in patients with acute ischaemic stroke (EMPHASIS): a multicentre, double-blind, randomised controlled trial

Key Points

• Minocycline demonstrates potential benefits in acute ischaemic stroke patients, improving overall outcomes.
• Safety outcomes are consistently monitored throughout the multicentre trial, ensuring participant well-being.
• Double-blind methodology reduces bias, allowing for more accurate assessment of minocycline's efficacy.
• Findings suggest that minocycline could emerge as a viable treatment option for acute ischaemic stroke.